Sustained release pharmaceutical compositions
US10463648B2 · kind B2 · utility
2Cited by
23References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 8, 2018 |
| Grant date | Nov 5, 2019 |
| Priority date | — |
| Expiry date | Aug 8, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides controlled release dosage formulations of compounds having the Formula: or pharmaceutically acceptable salts thereof, and in particular, aplindore. The dosage forms are useful, inter alia, for reducing side effects from administration of such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.